Response to mold contamination of intravenous magnesium sulfate produced by a compounding pharmacy.
Yale-New Haven Hospital, New Haven, Connecticut.
John M
JM
Boyce
Yale-New Haven Hospital, New Haven, Connecticut.
Lorraine
L
Lee
Yale-New Haven Hospital, New Haven, Connecticut.
Jeffrey
J
Topal
Yale-New Haven Hospital, New Haven, Connecticut.
David R
DR
Peaper
Yale-New Haven Hospital, New Haven, Connecticut.
Thomas
T
Balcezak
D002487:Centers for Disease Control and Prevention, U.S.; D004339:Drug Compounding; D004340:Drug Contamination; D005658:Fungi / Q000302:isolation & purification*; D006801:Humans; D017053:Infection Control / Q000379:methods; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D009181:Mycoses / Q000517:prevention & control; D011159:Population Surveillance; D014481:United States; D014486:United States Food and Drug Administration
D008278:Magnesium Sulfate